Votre panier est vide
Commencez à ajouter des peptides de recherche à votre panier.
PARCOURIR LES PRODUITS
Research GradeGrowth & PerformanceGHRH Analogue
or 3 × 23,00 € interest-free
APPROUVÉ PAR LES CHERCHEURS
FDA-Approved Compound
Approved as Egrifta — one of the few GHRH analogues with full regulatory approval
>99% HPLC Purity
Every batch independently tested with full Certificate of Analysis included
Visceral Fat Specificity
Clinically demonstrated selective reduction of metabolically dangerous visceral fat
Enhanced GHRH Potency
N-terminal modification provides superior potency and stability over native GHRH
A synthetic GHRH analogue with a trans-3-hexenoic acid modification. FDA-approved (as Egrifta) for HIV-associated lipodystrophy, Tesamorelin is studied for its potent GH stimulation and visceral fat reduction properties.
Approved as Egrifta — one of the few GHRH analogues with full regulatory approval
Every batch independently tested with full Certificate of Analysis included
Clinically demonstrated selective reduction of metabolically dangerous visceral fat
N-terminal modification provides superior potency and stability over native GHRH
Choose your preferred bacteriostatic water volume for body composition or metabolic research protocols.
Calculate exact doses for your GHRH research protocol. FDA studies used 2mg daily — reconstitute to your research needs.
Lyophilized form stable for 24+ months when stored properly at 2-8°C. The N-terminal modification enhances stability over native GHRH.
Research-grade Tesamorelin at accessible pricing compared to pharmaceutical branded Egrifta.
Allow vial to reach room temperature before reconstitution
Add 1 mL bacteriostatic water slowly along the vial wall
Gently swirl until fully dissolved — do not shake
Draw desired dose using an insulin syringe
Inject subcutaneously in the abdomen
Store reconstituted vial refrigerated at 2-8°C
Utilisez toujours une aiguille stérile neuve pour chaque administration. Éliminez les aiguilles usagées dans un conteneur à aiguilles approprié. Conservez le stylo au réfrigérateur entre 2 et 8°C.
Stack discount applied
Tesamorelin
69,00 €
This product
Sermorelin
55,00 €
CJC-1295
55,00 €
Prix du lot — économisez 17,90 € avec cette combinaison
Modified GHRH analogue (full-length with N-terminal modification)
C221H366N72O67S1
5,135.8 g/mol
Approximately 26-38 minutes
trans-3-Hexenoic acid-GHRH(1-44)-NH2
Tesamorelin is a synthetic GHRH analogue with a trans-3-hexenoic acid group attached to the tyrosine at position 1. This modification confers greater potency and stability than native GHRH. It stimulates pituitary GH release through GHRH receptors, with particular efficacy in reducing visceral adipose tissue.
Approved as Egrifta for treatment of HIV-associated lipodystrophy, demonstrating significant visceral fat reduction in Phase 3 trials.
Observed improvement in cognitive function and executive functioning in adults with mild cognitive impairment and HIV.
Phase 2b trial demonstrated reduction in hepatic fat fraction in adults with HIV and NAFLD treated with Tesamorelin.
“Access to research-grade Tesamorelin at this purity is excellent. Our visceral fat studies require absolute consistency and Peptides Pharma delivers.”
Dr. S. Grinspoon
Metabolic Research, Boston
“The N-terminal modification clearly provides enhanced potency in our GHRH receptor studies. Excellent quality and documentation.”
Dr. J. Veldhuis
Neuroendocrine Lab, Charlottesville
“We've been ordering Tesamorelin monthly for our longitudinal body composition study. Every batch is on specification.”
Dr. M. Falutz
HIV Metabolic Research, Montreal
“Tesamorelin vials arrived in excellent condition. HPLC purity >99% confirmed independently. The lyophilized formulation is well-characterised and stable. Peptides Pharma's documentation meets our institutional standards.”
Dr. M. Costa
Porto, Portugal
Both are GHRH analogues, but Tesamorelin includes the full 44-amino acid GHRH sequence with an N-terminal trans-3-hexenoic acid modification. This makes it more potent and stable than Sermorelin (GHRH 1-29). Tesamorelin also has FDA approval for lipodystrophy.
COA inclus avec chaque commande. Rapports spécifiques par lot disponibles sur demande.
See how Peptides Pharma pre-mixed research vials compare to traditional vials and other suppliers.
| Feature | Peptides Pharma Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Lyophilized vial | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Ce produit est destiné à la recherche et à l'usage en laboratoire uniquement. Pas pour la consommation humaine.
Système de stylo premium avec dosage entièrement ajustable. Fabriqué GMP, pureté >99% garantie.
Buy Tesamorelin >99% purity, GMP certified. FDA-approved GHRH analogue for visceral fat & IGF-1 research. Vials from €99 with worldwide delivery.
COMPARISONCompare Sermorelin and Tesamorelin for GH research. GHRH analogues, mechanisms, clinical evidence, and lipodystrophy data. Buy >99% purity research peptides.
ENCYCLOPEDIAGastric Pentadecapeptide. Molecular weight: 1419.53 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEThe most studied peptide duo in tissue regeneration research
PROTOCOLResearch protocol combining BPC-157 and TB-500 lyophilized vials for accelerated tissue recovery. Explore synergistic healing mechanisms, dosing schedules, and published study findings.
FAQTesamorelin research FAQ. Learn about this GHRH analogue, visceral fat research, growth hormone stimulation, purity, storage, and research applications.
CATEGORYResearch-grade recovery research vials. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss research vials. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Lyophilized vials, >99% purity, worldwide delivery.
